Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$762K Buy
1,996
+429
+27% +$167K 0.03% 515
2026
Q2
$622K Buy
1,567
+696
+80% +$198K 0.02% 556
2026
Q1
$151K Sell
871
-987
-53% -$202K 0.01% 1330
2025
Q4
$476K Sell
1,858
-251
-12% -$65.8K 0.02% 546
2025
Q3
$549K Buy
2,109
+260
+14% +$68.4K 0.03% 479
2025
Q2
$452K Sell
1,849
-1,103
-37% -$275K 0.03% 521
2025
Q1
$781K Buy
2,952
+1,046
+55% +$283K 0.06% 296
2024
Q4
$484K Buy
1,906
+554
+41% +$149K 0.04% 373
2024
Q3
$428K Buy
1,352
+593
+78% +$211K 0.04% 373
2024
Q2
$284K Buy
759
+425
+127% +$143K 0.04% 401
2024
Q1
$116K Sell
334
-26
-7% -$9.85K 0.02% 590
2023
Q4
$136K Buy
+360
New +$177K 0.04% 425

Other funds holding HUM

GAMMA Investing's HUM Position: Q3 2026 in Review

GAMMA Investing increased its Humana (HUM) stake by 27% in Q3 2026, buying an estimated $167K and bringing the position to 1,996 shares worth $762K. The position accounts for 0.03% of the portfolio, ranked #515.

GAMMA Investing first reported a position in HUM in Q4 2023 and has held it in 12 quarters since. The position peaked at $781K in Q1 2025. 37 funds tracked by Wall St. Rank hold HUM as of Q3 2026.

  • GAMMA Investing held 1,996 shares of Humana worth $762K as of Q3 2026.
  • GAMMA Investing bought 429 Humana shares in Q3 2026, an estimated $167K.
  • Humana made up 0.03% of GAMMA Investing's portfolio in Q3 2026, its #515 holding.
  • GAMMA Investing first reported a position in Humana in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Humana position peaked at $781K in Q1 2025.
  • 37 funds tracked by Wall St. Rank held Humana as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.